Ubs Group Ag Olema Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 77,547 shares of OLMA stock, worth $642,089. This represents 0.0% of its overall portfolio holdings.

Number of Shares

77,547

Previous 158,625 51.11%

Holding current value

$642,089

Previous $1.72 Million 46.1%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.41 - $16.46 $844,021 - $1.33 Million	-81,078 Reduced 51.11%	77,547 $925,000
Q2 2024 Aug 13, 2024	SELL	$8.73 - $13.99 $126,899 - $203,358	-14,536 Reduced 8.39%	158,625 $1.72 Million
Q1 2024 May 13, 2024	BUY	$10.95 - $16.62 $1.32 Million - $2.01 Million	120,663 Added 229.84%	173,161 $1.96 Million
Q4 2023 Feb 09, 2024	BUY	$10.53 - $17.14 $405,352 - $659,804	38,495 Added 274.91%	52,498 $736,000
Q3 2023 Nov 09, 2023	BUY	$8.19 - $12.98 $102,317 - $162,159	12,493 Added 827.35%	14,003 $172,000
Q2 2023 Aug 11, 2023	BUY	$3.22 - $9.65 $3,715 - $11,136	1,154 Added 324.16%	1,510 $13,000
Q1 2023 May 12, 2023	SELL	$2.55 - $4.97 $9,516 - $18,548	-3,732 Reduced 91.29%	356 $1,000
Q4 2022 Feb 08, 2023	BUY	$2.27 - $3.76 $3,761 - $6,230	1,657 Added 68.16%	4,088 $10,000
Q3 2022 Nov 10, 2022	BUY	$2.72 - $5.88 $6,612 - $14,294	2,431 New	2,431 $7,000
Q2 2022 Aug 10, 2022	SELL	$2.04 - $4.61 $53 - $119	-26 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.89 - $9.43 $404 - $980	-104 Reduced 80.0%	26 $0
Q4 2021 Feb 14, 2022	BUY	$8.75 - $30.71 $1,137 - $3,992	130 New	130 $1,000
Q2 2021 Aug 13, 2021	SELL	$21.15 - $36.14 $13,451 - $22,985	-636 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$27.81 - $53.64 $1.46 Million - $2.82 Million	-52,617 Reduced 98.81%	636 $21,000
Q4 2020 Feb 11, 2021	BUY	$37.09 - $54.5 $1.98 Million - $2.9 Million	53,253 New	53,253 $2.56 Million

Others Institutions Holding OLMA

# of Institutions

136

Shares Held

58.7M

Call Options Held

141K

Put Options Held

23.1K

View Full List

About Olema Pharmaceuticals, Inc.

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $335M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

More about OLMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account